<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03900000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P19438</UniProt_ID>
  <Seq_Length>455</Seq_Length>
  <Molecule_Weight>50495</Molecule_Weight>
  <KEGG_ID>hsa:7132</KEGG_ID>
  <Orthology_ID>K03158</Orthology_ID>
  <EBI_ID>EBI-299451</EBI_ID>
  <Function_Summary>Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase.</Function_Summary>
  <Pfam_ID>PF00531:Death@@PF00020:TNFR_c6</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>38</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Tumor necrosis factor receptor I</Alias>
      <Alias>Tumor necrosis factor receptor type 1</Alias>
      <Alias>Tumor necrosis factor receptor type I</Alias>
      <Alias>TNFR-I</Alias>
      <Alias>Tumor necrosis factor binding protein 1</Alias>
      <Alias>TNF-RI</Alias>
      <Alias>Tumor necrosis factor receptor 1A isoform beta</Alias>
      <Alias>Tumor necrosis factor-alpha receptor</Alias>
      <Alias>TNF-R1</Alias>
      <Alias>Tumor necrosis factor receptor 1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with tumor necrosis factor, a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function.</Detail>
      <Keyword>Tumor necrosis factor receptor activity</Keyword>
      <Ontology_ID>GO:0005031</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>117</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>62</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>305</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>51</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>62</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>115</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>99</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>81</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of an I-kappaB kinase/NF-kappaB induced cascade.</Detail>
      <Keyword>Positive regulation of I-kappaB kinase/NF-kappaB cascade</Keyword>
      <Ontology_ID>GO:0043123</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Positive regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process induced by extracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by extracellular signals</Keyword>
      <Ontology_ID>GO:0008624</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring due to the formation of a bond between two carbons of a fatty acid. They have a wide range of biological activities.</Detail>
      <Keyword>Prostaglandin metabolic process</Keyword>
      <Ontology_ID>GO:0006693</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.</Detail>
      <Keyword>Cellular response to mechanical stimulus</Keyword>
      <Ontology_ID>GO:0071260</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat1 protein.</Detail>
      <Keyword>Positive regulation of tyrosine phosphorylation of Stat1 protein</Keyword>
      <Ontology_ID>GO:0042511</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR</Protein_Seq>
    <DNA_Seq>CGGCCCAGTGATCTTGAACCCCAAAGGCCAGAACTGGAGCCTCAGTCCAGAGAATTCTGAGAAAATTAAAGCAGAGAGGAGGGGAGAGATCACTGGGACCAGGCCGTGATCTCTATGCCCGAGTCTCAACCCTCAACTGTCACCCCAAGGCACTTGGGACGTCCTGGACAGACCGAGTCCCGGGAAGCCCCAGCACTGCCGCTGCCACACTGCCCTGAGCCCAAATGGGGGAGTGAGAGGCCATAGCTGTCTGGCATGGGCCTCTCCACCGTGCCTGACCTGCTGCTGCCGCTGGTGCTCCTGGAGCTGTTGGTGGGAATATACCCCTCAGGGGTTATTGGACTGGTCCCTCACCTAGGGGACAGGGAGAAGAGAGATAGTGTGTGTCCCCAAGGAAAATATATCCACCCTCAAAATAATTCGATTTGCTGTACCAAGTGCCACAAAGGAACCTACTTGTACAATGACTGTCCAGGCCCGGGGCAGGATACGGACTGCAGGGAGTGTGAGAGCGGCTCCTTCACCGCTTCAGAAAACCACCTCAGACACTGCCTCAGCTGCTCCAAATGCCGAAAGGAAATGGGTCAGGTGGAGATCTCTTCTTGCACAGTGGACCGGGACACCGTGTGTGGCTGCAGGAAGAACCAGTACCGGCATTATTGGAGTGAAAACCTTTTCCAGTGCTTCAATTGCAGCCTCTGCCTCAATGGGACCGTGCACCTCTCCTGCCAGGAGAAACAGAACACCGTGTGCACCTGCCATGCAGGTTTCTTTCTAAGAGAAAACGAGTGTGTCTCCTGTAGTAACTGTAAGAAAAGCCTGGAGTGCACGAAGTTGTGCCTACCCCAGATTGAGAATGTTAAGGGCACTGAGGACTCAGGCACCACAGTGCTGTTGCCCCTGGTCATTTTCTTTGGTCTTTGCCTTTTATCCCTCCTCTTCATTGGTTTAATGTATCGCTACCAACGGTGGAAGTCCAAGCTCTACTCCATTGTTTGTGGGAAATCGACACCTGAAAAAGAGGGGGAGCTTGAAGGAACTACTACTAAGCCCCTGGCCCCAAACCCAAGCTTCAGTCCCACTCCAGGCTTCACCCCCACCCTGGGCTTCAGTCCCGTGCCCAGTTCCACCTTCACCTCCAGCTCCACCTATACCCCCGGTGACTGTCCCAACTTTGCGGCTCCCCGCAGAGAGGTGGCACCACCCTATCAGGGGGCTGACCCCATCCTTGCGACAGCCCTCGCCTCCGACCCCATCCCCAACCCCCTTCAGAAGTGGGAGGACAGCGCCCACAAGCCACAGAGCCTAGACACTGATGACCCCGCGACGCTGTACGCCGTGGTGGAGAACGTGCCCCCGTTGCGCTGGAAGGAATTCGTGCGGCGCCTAGGGCTGAGCGACCACGAGATCGATCGGCTGGAGCTGCAGAACGGGCGCTGCCTGCGCGAGGCGCAATACAGCATGCTGGCGACCTGGAGGCGGCGCACGCCGCGGCGCGAGGCCACGCTGGAGCTGCTGGGACGCGTGCTCCGCGACATGGACCTGCTGGGCTGCCTGGAGGACATCGAGGAGGCGCTTTGCGGCCCCGCCGCCCTCCCGCCCGCGCCCAGTCTTCTCAGATGAGGCTGCGCCCCTGCGGGCAGCTCTAAGGACCGTCCTGCGAGATCGCCTTCCAACCCCACTTTTTTCTGGAAAGGAGGGGTCCTGCAGGGGCAAGCAGGAGCTAGCAGCCGCCTACTTGGTGCTAACCCCTCGATGTACATAGCTTTTCTCAGCTGCCTGCGCGCCGCCGACAGTCAGCGCTGTGCGCGCGGAGAGAGGTGCGCCGTGGGCTCAAGAGCCTGAGTGGGTGGTTTGCGAGGATGAGGGACGCTATGCCTCATGCCCGTTTTGGGTGTCCTCACCAGCAAGGCTGCTCGGGGGCCCCTGGTTCGTCCCTGAGCCTTTTTCACAGTGCATAAGCAGTTTTTTTTGTTTTTGTTTTGTTTTGTTTTGTTTTTAAATCAATCATGTTACACTAATAGAAACTTGGCACTCCTGTGCCCTCTGCCTGGACAAGCACATAGCAAGCTGAACTGTCCTAAGGCAGGGGCGAGCACGGAACAATGGGGCCTTCAGCTGGAGCTGTGGACTTTTGTACATACACTAAAATTCTGAAGTT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>TNFRSF1A</Gene_Name>
    <Gene_Alias>TNFAR; TNFR1</Gene_Alias>
    <Gene_ID>7132</Gene_ID>
    <Genbank_ACCN>NM_001065</Genbank_ACCN>
    <Protein_ACCN>NP_001056</Protein_ACCN>
    <HGNC_ID>11916</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7132</Gene_URL>
    <UCSC_ID>uc010sey.2</UCSC_ID>
    <EMBL_ID>ENSG00000067182</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P01375</Uniprot_ID>
      <Gene_Name>TNF</Gene_Name>
      <EBI_ID>EBI-359977</EBI_ID>
      <PPI_EBI_URL>EBI-299451,EBI-359977</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q15628</Uniprot_ID>
      <Gene_Name>TRADD</Gene_Name>
      <EBI_ID>EBI-359215</EBI_ID>
      <PPI_EBI_URL>EBI-299451,EBI-359215</PPI_EBI_URL>
      <Experiment_Number>10</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13546</Uniprot_ID>
      <Gene_Name>RIPK1</Gene_Name>
      <EBI_ID>EBI-358507</EBI_ID>
      <PPI_EBI_URL>EBI-299451,EBI-358507</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Systemic Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Systemic Lupus Erythematosus</Disease_Detail>
      <Disease_DB>SYS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/systemic_lupus_erythematosus?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Relapsing Fever</Disease_Name>
      <Disease_Detail>Relapsing Fever</Disease_Detail>
      <Disease_DB>RLP003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/relapsing_fever?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Palindromic Rheumatism</Disease_Name>
      <Disease_Detail>Palindromic Rheumatism</Disease_Detail>
      <Disease_DB>PLN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/palindromic_rheumatism?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Periodic Fever, Familial, Autosomal Dominant</Disease_Name>
      <Disease_Detail>Periodic Fever, Familial</Disease_Detail>
      <Disease_DB>PRD013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/periodic_fever_familial_autosomal_dominant?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Post-Transplant Lymphoproliferative Disease</Disease_Name>
      <Disease_Detail>Post-Transplant Lymphoproliferative Disease</Disease_Detail>
      <Disease_DB>PST046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/post_transplant_lymphoproliferative_disease?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Periodic Fever, Familial</Disease_Name>
      <Disease_Detail>Periodic Fever, Familial</Disease_Detail>
      <Disease_DB>PRD019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/periodic_fever_familial?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rheumatoid Arthritis</Disease_Name>
      <Disease_Detail>Rheumatoid Arthritis</Disease_Detail>
      <Disease_DB>RHM011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rheumatoid_arthritis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Paratyphoid Fever</Disease_Name>
      <Disease_Detail>Paratyphoid Fever</Disease_Detail>
      <Disease_DB>PRT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/paratyphoid_fever?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Muckle-Wells Syndrome</Disease_Name>
      <Disease_Detail>Muckle-Wells Syndrome</Disease_Detail>
      <Disease_DB>MCK007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/muckle_wells_syndrome?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Wells Syndrome</Disease_Name>
      <Disease_Detail>Wells Syndrome</Disease_Detail>
      <Disease_DB>WLL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/wells_syndrome?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spondylitis</Disease_Name>
      <Disease_Detail>Spondylitis</Disease_Detail>
      <Disease_DB>SPN051</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spondylitis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Mediterranean Fever</Disease_Name>
      <Disease_Detail>Familial Mediterranean Fever</Disease_Detail>
      <Disease_DB>FML018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_mediterranean_fever?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intestinal Disease</Disease_Name>
      <Disease_Detail>Intestinal Disease</Disease_Detail>
      <Disease_DB>INT068</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intestinal_disease?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multiple Sclerosis</Disease_Name>
      <Disease_Detail>Multiple Sclerosis</Disease_Detail>
      <Disease_DB>MLT020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multiple_sclerosis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sympathetic Ophthalmia</Disease_Name>
      <Disease_Detail>Sympathetic Ophthalmia</Disease_Detail>
      <Disease_DB>SYM002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sympathetic_ophthalmia?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tendinosis</Disease_Name>
      <Disease_Detail>Tendinosis</Disease_Detail>
      <Disease_DB>TND006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tendinosis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cowpox</Disease_Name>
      <Disease_Detail>Cowpox</Disease_Detail>
      <Disease_DB>CWP001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cowpox?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pericarditis</Disease_Name>
      <Disease_Detail>Pericarditis</Disease_Detail>
      <Disease_DB>PRC013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pericarditis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyper-Igd Syndrome</Disease_Name>
      <Disease_Detail>Hyper-Igd Syndrome</Disease_Detail>
      <Disease_DB>HYP088</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyper_igd_syndrome?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Paracoccidioidomycosis</Disease_Name>
      <Disease_Detail>Paracoccidioidomycosis</Disease_Detail>
      <Disease_DB>PRC002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/paracoccidioidomycosis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pediatric Systemic Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Pediatric Systemic Lupus Erythematosus</Disease_Detail>
      <Disease_DB>PDT035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pediatric_systemic_lupus_erythematosus?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multiple Sclerosis 5</Disease_Name>
      <Disease_Detail>Multiple Sclerosis</Disease_Detail>
      <Disease_DB>MLT124</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multiple_sclerosis_5?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Idiopathic Recurrent Pericarditis</Disease_Name>
      <Disease_Detail>Idiopathic Recurrent Pericarditis</Disease_Detail>
      <Disease_DB>IDP041</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_recurrent_pericarditis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intermittent Hydrarthrosis</Disease_Name>
      <Disease_Detail>Intermittent Hydrarthrosis</Disease_Detail>
      <Disease_DB>INT182</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intermittent_hydrarthrosis?search=TNFRSF1A#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>EXTRACELLULAR DOMAIN OF THE 55KDA TUMOR NECROSIS FACTOR RECEPTOR. CRYSTALLIZED AT PH3.7 IN P 21 21 21</PDB_Title>
      <PDB_ID>1EXT</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1EXT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>MAGNESIUM ION$SULFATE ION</Ligand_Name>
      <PubMed_Title>Structures of the extracellular domain of the type I tumor necrosis factor receptor.</PubMed_Title>
      <Author>Naismith J.H, et al.</Author>
      <Journal>Structure. 1996 Nov 15;4(11):1251-62.</Journal>
      <PubMed_ID>8939750</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PHOTOCHEMICALLY-ENHANCED BINDING OF SMALL MOLECULES TO THE TUMOR NECROSIS FACTOR RECEPTOR-1</PDB_Title>
      <PDB_ID>1FT4</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1FT4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5-(3-MORPHOLIN-4-YL-PROPYL)-2-(3-NITRO-PHENYL)- 4-THIOXO-4,5-DIHYDRO-1-THIA-3B,5
-DIAZA-CYCLOPENTA[A]PENTALEN- 6-ONE</Ligand_Name>
      <PubMed_Title>Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.</PubMed_Title>
      <Author>Carter P.H, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):11879-84</Journal>
      <PubMed_ID>11592999</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A NEW PARADIGM FOR TUMOR NECROSIS FACTOR SIGNALLING</PDB_Title>
      <PDB_ID>1NCF</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1NCF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor.</PubMed_Title>
      <Author>Naismith J.H, et al.</Author>
      <Journal>J Biol Chem. 1995 Jun 2;270(22):13303-7.</Journal>
      <PubMed_ID>7768931</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX: IMPLICATIONS FOR TNF RECEPTOR ACTIVATION</PDB_Title>
      <PDB_ID>1TNR</PDB_ID>
      <Resolution>2.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1TNR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.</PubMed_Title>
      <Author>Banner D.W, et al.</Author>
      <Journal>Cell. 1993 May 7;73(3):431-45.</Journal>
      <PubMed_ID>8387891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE TUMOR NECROSIS FACTOR RECEPTOR-1 DEATH DOMAIN</PDB_Title>
      <PDB_ID>1ICH</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ICH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the tumor necrosis factor receptor-1 death domain.</PubMed_Title>
      <Author>Sukits SF, et al.</Author>
      <Journal>J Mol Biol.2001 Jul 20;310(4):895-906.</Journal>
      <PubMed_ID>11453696</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05145</Pathway_ID>
      <Pathway_Title>Toxoplasmosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05010</Pathway_ID>
      <Pathway_Title>Alzheimer's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04060</Pathway_ID>
      <Pathway_Title>Cytokine-cytokine receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04668</Pathway_ID>
      <Pathway_Title>TNF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05166</Pathway_ID>
      <Pathway_Title>HTLV-I infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04380</Pathway_ID>
      <Pathway_Title>Osteoclast differentiation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Development</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04920</Pathway_ID>
      <Pathway_Title>Adipocytokine signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04210</Pathway_ID>
      <Pathway_Title>Apoptosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05014</Pathway_ID>
      <Pathway_Title>Amyotrophic lateral sclerosis (ALS)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04932</Pathway_ID>
      <Pathway_Title>Non-alcoholic fatty liver disease (NAFLD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05152</Pathway_ID>
      <Pathway_Title>Tuberculosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05142</Pathway_ID>
      <Pathway_Title>Chagas disease (American trypanosomiasis)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05142</Pathway_ID>
      <Pathway_Title>Chagas disease (American trypanosomiasis)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Small proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.h.cg.b.b.b.html</SCOP_URL>
    <CATH_Class>Mainly beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1ext</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03900001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03900055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>